Anzeige
Meldung des Tages: Ein Gold-Asset in der Champions League der Geologie – Erstklassige Lage im „Land der Giganten“

PTC Therapeutics Aktie News

Aktie
WKN:  A1W0MW ISIN:  US69366J2006 US-Symbol:  PTCT Branche:  Biotechnologie Land:  USA
69,33 $
-0,51 $
-0,73%
58,873 € 17:26:03 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
8,64
Index-Zuordnung
-

PTC Therapeutics News

19.02.26 - PR Newswire
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire
12.02.26 - PR Newswire
PTC Therapeutics Provides Regulatory Update on Translarna™
PTC Therapeutics Provides Regulatory Update on Translarna™ PR Newswire
05.02.26 - PR Newswire
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 PR Newswire
12.01.26 - PR Newswire
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference PR Newswire
08.01.26 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
22.12.25 - PR Newswire
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan PR Newswire
19.12.25 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
18.12.25 - PR Newswire
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
01.12.25 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
24.11.25 - PR Newswire
Sandisk Set to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600
Sandisk Set to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600 PR Newswire
20.11.25 - PR Newswire
PTC Therapeutics to Host R&D Day
PTC Therapeutics to Host R&D Day PR Newswire
04.11.25 - PR Newswire
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results PR Newswire
31.10.25 - PR Newswire
PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics to Participate at Upcoming Investor Conferences PR Newswire
27.10.25 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
21.10.25 - PR Newswire
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results PR Newswire
01.10.25 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
04.09.25 - wallstreetONLINE Redaktion
Favoritenliste: JPMorgan kürt neue Favoriten: Diese Aktien haben im September großes Potenzial
JPMorgan hat seine Favoritenliste für September neu aufgestellt. Mit dabei sind PTC Therapeutics, Armstrong World Industries und McCormick. Die Hintergründe. Die Analysten von ...
21.08.25 - PR Newswire
PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics to Participate at Upcoming Investor Conferences PR Newswire
19.08.25 - PR Newswire
PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA
PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA PR Newswire
07.08.25 - PR Newswire
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results PR Newswire

Newssuche

Videos

newspaper
18.02.26 -2,78%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Antimon-Preis verdreifacht
Antimony Resources Corp
0,463 €
-2,22%
Antimony Resources Corp Chart
Startet jetzt der nächste Rohstoff-Run?
Mehr zur Aktie »